Literature DB >> 11290392

Effects of acute and repeated restraint stress on corticotropin-releasing hormone binding protein mRNA in rat amygdala and dorsal hippocampus.

K A Lombardo1, R J Herringa, J S Balachandran, D T Hsu, V P Bakshi, P H Roseboom, N H Kalin.   

Abstract

Corticotropin-releasing hormone (CRH) mediates endocrine, behavioral, and autonomic responses to stress. In addition to binding to two receptor subtypes, CRH binds to a CRH-binding protein (CRH-BP). While CRH-BP is hypothesized to play a role in regulating levels of free CRH and modulating the stress response, the effects of stressors on brain CRH-BP are relatively unexplored. The present study determined effects of acute and repeated restraint on CRH-BP mRNA in basolateral amygdala (BLA) and dorsal hippocampus (DH), brain regions involved in fear and motivation. Using in situ hybridization, we found that a single acute period of restraint significantly increased CRH-BP mRNA in BLA by 20% but had no effect in DH. Repeated restraint had no effect on basal levels of CRH-BP mRNA in BLA or DH. Importantly, repeated restraint blocked the effects of acute restraint in the BLA. These results demonstrate differential effects of acute and repeated restraint on CRH-BP mRNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290392     DOI: 10.1016/s0304-3940(01)01680-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Predator threat induces behavioral inhibition, pituitary-adrenal activation and changes in amygdala CRF-binding protein gene expression.

Authors:  Patrick H Roseboom; Steven A Nanda; Vaishali P Bakshi; Andrea Trentani; Sarah M Newman; Ned H Kalin
Journal:  Psychoneuroendocrinology       Date:  2006-11-20       Impact factor: 4.905

2.  Pituitary CRH-binding protein and stress in female mice.

Authors:  Gwen S Stinnett; Nicole J Westphal; Audrey F Seasholtz
Journal:  Physiol Behav       Date:  2015-02-27

3.  Structural Brain Development and Aggression: A Longitudinal Study in Late Childhood.

Authors:  Hannah Roberts; Elena Pozzi; Nandita Vijayakumar; Sally Richmond; Katherine Bray; Camille Deane; Sarah Whittle
Journal:  Cogn Affect Behav Neurosci       Date:  2021-02-18       Impact factor: 3.282

4.  Increased protein and mRNA expression of corticotropin-releasing factor (CRF), decreased CRF receptors and CRF binding protein in specific postmortem brain areas of teenage suicide subjects.

Authors:  Ghanshyam N Pandey; Hooriyah S Rizavi; Runa Bhaumik; Xinguo Ren
Journal:  Psychoneuroendocrinology       Date:  2019-04-15       Impact factor: 4.905

Review 5.  Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.

Authors:  Kyle D Ketchesin; Gwen S Stinnett; Audrey F Seasholtz
Journal:  Stress       Date:  2017-05-18       Impact factor: 3.493

6.  Deletion of corticotropin-releasing factor binding protein selectively impairs maternal, but not intermale aggression.

Authors:  S C Gammie; A F Seasholtz; S A Stevenson
Journal:  Neuroscience       Date:  2008-09-27       Impact factor: 3.590

Review 7.  Regulatory Pathways of Monoamine Oxidase A during Social Stress.

Authors:  Yuki Higuchi; Tomoko Soga; Ishwar S Parhar
Journal:  Front Neurosci       Date:  2017-10-31       Impact factor: 4.677

8.  Sex differences in stress-related receptors: ″micro″ differences with ″macro″ implications for mood and anxiety disorders.

Authors:  Debra A Bangasser
Journal:  Biol Sex Differ       Date:  2013-01-21       Impact factor: 5.027

9.  Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions.

Authors:  Chang-peng Shen; Yelena Tsimberg; Christopher Salvadore; Emanuel Meller
Journal:  BMC Neurosci       Date:  2004-09-20       Impact factor: 3.288

10.  Maternal stress and the MPOA: Activation of CRF receptor 1 impairs maternal behavior and triggers local oxytocin release in lactating rats.

Authors:  Stefanie M Klampfl; Milena M Schramm; Barbara M Gaßner; Katharina Hübner; Audrey F Seasholtz; Paula J Brunton; Doris S Bayerl; Oliver J Bosch
Journal:  Neuropharmacology       Date:  2018-03-02       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.